May 2021
In addition to several patents granted in the US, Europe, Asia, one more patent has been granted in Canada.
Mar 2021
NIC-OHPP-101 drug has shown superior in vivo bioavailability unmatched by any other niclosamide oral drug.
May 2020
Phytoption positions its NIC-OHPP-101 antiviral therapeutics to fight COVID-19.
Feb. 2018
Phytoption won the National Science Foundation SBIR-TECP award.
Mar. 2016
Phytoption won the National Science Foundation SBIR award.
Nov. 2015
Phytoption won BioCrossroad Business Venture Competition in Indianapolis, Indiana
Jan. 2014
Phytoption won the National Science Foundation STTR award.
Nov. 2013
Phytoption won award in the Global Food and Health Innovation Challenge in Nashville, Tennessee.
